Guest guest Posted December 30, 2004 Report Share Posted December 30, 2004 Which makes this " dual " receptor blocker even more interesting. There is concern that blocking CCR5 could lead to more CXCR4 viruses, which is probably not a good thing. It is very encouraging that new classes of drugs are continuing to appear, although some may prefer tumeric. JB On Dec 30, 2004, at 10:37 AM, PozHealth wrote: > Subject: Re: Dual CCR5/CXCR4 Antagonist Blocks HIV Entry and Infection > > An AMD CXCR4 antagonist is scheduled to begin phase II study in > patients in > the ACTG. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.